Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1045-2019Class II

JOURNEY II XR TIBIAL POSTERIOR KEEL PUNCH SZ 7-8 , REF 74013988 The JOURNEY II XR Tibial Posterior Keel Punch...

Smith & Nephew, Inc. / initiated 2018-12-10 / Terminated / root cause: design

Smith & Nephew, Inc. began a recall of JOURNEY II XR TIBIAL POSTERIOR KEEL PUNCH SZ 7-8 , REF 74013988 The JOURNEY II XR Tibial Posterior Keel Punch is a reusable surgical instrument used to prepare... on . FDA classified it as Class II and gives the reason as "Higher than anticipated occurrence of bone fracture during the use of the XR Tibia Posterior Punch". As of , the recall status on record is Terminated, and MDM tags the root cause as design.

Recall record

Recall number
Z-1045-2019
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Smith & Nephew, Inc.
Product
JOURNEY II XR TIBIAL POSTERIOR KEEL PUNCH SZ 7-8 , REF 74013988 The JOURNEY II XR Tibial Posterior Keel Punch is a reusable surgical instrument used to prepare the proximal tibial to receive a JOURNEY II XR tibial baseplate.
Product code
JWH Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer
Reason for recall
Higher than anticipated occurrence of bone fracture during the use of the XR Tibia Posterior Punch
Root cause tag
design
FDA root cause
Device Design
Action
The firm, smith&nephew, initiated the recall by email with an "Urgent Medical Device Recall Notice" letter dated 12/10/18 to the customers on 12/10/2018. Letter describes the product, problem and actions to be taken. The customers were instructed to do the following: -Inspect your inventory and locate any devices from the listed product and batch numbers and quarantine them immediately. - If you are a distributor, you must notify your customers of the field action and ensure that these actions are carried out. -Complete and return the Response Form to [email protected] or fax to 901-566-7975. Please Note even if you have no product to return, this form must be completed, signed and returned. If you have any questions or concerns regarding this recall please contact [email protected].
Quantity in commerce
46 units
Distribution
US Distribution to OR and TN; and Internationally to: Japan.
Product codes and lots
Batch Numbers: 17JGA0023; 17JGA0023A; 17JGA0023C; 17JGA0029; 17JGA0029A; 17JGA0029B; 17JGA0035A; 17JGA0035C; 17JGA0045B; 17JGA0045C; 17JGA0045D & 17JGA0045R

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1045-2019
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1042-2019Class IITerminatedVoluntary: Firm initiated
Z-1043-2019Class IITerminatedVoluntary: Firm initiated
Z-1044-2019Class IITerminatedVoluntary: Firm initiated
Z-1045-2019Class IITerminatedVoluntary: Firm initiated